Crinetics Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic from 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Crinetics Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to Q3 2025.
  • Crinetics Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 94.2M shares, a 17.6% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 80.8M shares, a 39.1% increase from 2023.
  • Crinetics Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 58.1M shares, a 11.7% increase from 2022.
  • Crinetics Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 52M shares, a 35.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Crinetics Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 94.2M +14.1M +17.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 93.8M +14.8M +18.7% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 93.1M +20.8M +28.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 80.8M +22.7M +39.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 80.1M +23.3M +41% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 79M +24.7M +45.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 72.3M +18.4M +34.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 58.1M +6.09M +11.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 56.8M +3.04M +5.65% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 54.3M +1.75M +3.34% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 53.9M +6.2M +13% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 52M Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 53.8M +15.5M +40.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 52.5M +15.5M +41.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 47.7M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 38.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 37.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12

Crinetics Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 80.8M +22.7M +39.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 58.1M +6.09M +11.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 52M +13.5M +35.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 38.4M +7.99M +26.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 30.4M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.